SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-215344
Filing Date
2019-08-07
Accepted
2019-08-07 16:15:21
Documents
65
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d760010d10q.htm   iXBRL 10-Q 2528330
2 EX-3.1 d760010dex31.htm EX-3.1 53037
3 EX-31.1 d760010dex311.htm EX-31.1 6482
4 EX-31.2 d760010dex312.htm EX-31.2 6574
5 EX-32.1 d760010dex321.htm EX-32.1 3950
6 EX-32.2 d760010dex322.htm EX-32.2 3938
  Complete submission text file 0001193125-19-215344.txt   8007684

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20190630.xsd EX-101.SCH 40005
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20190630_cal.xml EX-101.CAL 45756
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20190630_def.xml EX-101.DEF 229553
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20190630_lab.xml EX-101.LAB 386784
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20190630_pre.xml EX-101.PRE 334497
12 EXTRACTED XBRL INSTANCE DOCUMENT d760010d10q_htm.xml XML 1379906
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 191005634
SIC: 2834 Pharmaceutical Preparations